|
Glatiramer Acetate - Active Ingredient: Glatiramer Acetate; Concentration/Dosage: 40 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: S, Aciclovir - Active Ingredient: Aciclovir; Concentration/Dosage: 400 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Aliskiren - Active Ingredient: Aliskiren, Hemifumarate; Concentration/Dosage: 165.75 Mg; Equivalence: Equivalent To 150 Mg Of Aliskiren; Fa Form, Hemifumarate; Concentration/Dosage: 331.5 Mg; Equivalence: Equivalent To 300 Mg Of Aliskiren; Far Form, Amiodarone - Active Ingredient: Amiodarone, Hydrochloride; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compone, 01/20/2025, Anlodipine - Active Ingredient: Amlodipine, Besylate; Concentration/Dosage: 2.5 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Amlodipine + Associations - Active Ingredient (1): Amlodipine, Besylate; Active Ingredient (2): Ramipril; Concentration/Dosage: 5 Mg + 10 Mg; Pharmaceutical Form, Axetilcefuroxime - Active Ingredient: Axetilcefuroxime; Concentration/Dosage: 300.72 Mg (Equivalent To 250 Mg Of Cefuroxime); Pharmaceutical Form: Compri, Belzutifano - Active Ingredient: Belzutifano; Concentration/Dosage: 40 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Bendamustine - Active Ingredient: Bendamustine, Hydrochloride; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Powder For Infusion Solution; Presentation, Benfotiamine - Active Ingredient: Benfotiamine; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Betainterferon 1A Active Ingredient: Betainterferon 1A; Concentration/Dosage: 22 Mcg; Pharmaceutical Form: Injectable Solution; Presentation: Pre Syringe, Interferon Beta 1A Active Ingredient: Interferon Beta 1A; Concentration/Dosage: 44 Mcg (12 Mui); Pharmaceutical Form: Injectable Solution; Presentation: Se, Betahistina - Active Ingredient: Betahistina; Concentration/Dosage: 48 Mg; Pharmaceutical Form: Coated Extended Release Tablet; Presentation: Betamethasone + Associations - Active Ingredient (1): Betamethasone, Dipropionate; Active Ingredient (2): Gentamicin, Sulfate; Concentration/Dosage: 0.64 Mg, Valerate; Active Ingredient (2): Gentamicin, Sulfate + Tolnaftate + Clioquinol; Concent, Betaxolol - Active Ingredient: Betaxolol, Hydrochloride; Concentration/Dosage: 2.8 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle, Hydrochloride; Concentration/Dosage: 5 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle; C, Bilastine - Active Ingredient: Bilastine; Concentration/Dosage: 20 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Blinatumomab - Active Ingredient: Blinatumomab; Concentration/Dosage: 38.5 Mcg; Pharmaceutical Form: Lifolized Powder For Injectable Solution; Presentation, Bosutinib - Active Ingredient: Bosutinib Monohydrate; Concentration/Dosage: 500 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compon, Brigatinib - Active Ingredient: Brigatinib; Concentration/Dosage: 90 Mg + 180 Mg; Pharmaceutical Form: Coated Tablet; Presentation: 7 Tablets, Pinaverium Bromide - Active Ingredient: Pinaverium Bromide; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .;, Bromopride - Active Ingredient: Bromopride; Concentration/Dosage: 10 Mg; Pharmaceutical Form: Hard Gelatinous Capsule; Presentation: .; Component: .;, Candesartana - Active Principle
|
